PATIENT- AND PHYSICIAN-REPORTED OUTCOMES FROM RAJ4: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF PEFICITINIB (ASP015K) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) WHO HAD AN INADEQUATE RESPONSE TO METHOTREXATE (MTX)

Category Primary study
JournalANNALS OF THE RHEUMATIC DISEASES
Year 2019
This article has no abstract
Epistemonikos ID: d666ecc87758f74dd41a2dcecc413b4a05e77fd1
First added on: Mar 24, 2022